Atlas Trials

Safety, Tolerability, and Pharmacokinetics Study of NDX-1017

Clinical trial NCT03298672 · COMPLETED

Trial details

NCT number
NCT03298672
Sponsor
LeonaBio
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Alzheimer Disease
Start date
2017-10-09
Primary completion
2019-09-05
Enrollment
88

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.